By proceeding, you agree to our Terms of Use and Privacy Policy.
Avantor a Fortune 500 company is a leading global provider of mission-critical products and services to customers in the biopharma healthcare education & government and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225 000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. Our more than 12 000 Avantor associates are passionate about our mission: Setting science in motion to create a better world. We share enthusiasm for innovation excellence and achievement. We never settle for the status quo. Whether we are collaborating with our customers to advance science or solve multifaceted problems we help them reach their goals more efficiently and effectively.
22-24 February 2022
Join hundreds of industry leaders, government and higher education officials, biotechnology and pharma executives, medical device, medtech, health IT and life sciences supporters from across America on February 22-24, 2022 for SCBIO 2022 – South Caro
Event Ended
Hybrid
Paid
Charleston
22-23 March 2022
The SoCalBio Digital Health Conference is an annual event organized by the Southern California Biomedical Council (SoCalBio), the trade association of the bioscience and health industries in the Greater Los Angeles region.
USA
Long Beach
24-25 May 2022
Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget After a two year hiatus, Arena International are delighted to announce Outsourcing in Clinical Trials East Coast will be returning
King of Prussia
13-16 June 2022
As there is no substitute for in-person collaboration, BIO is back this year offering ample opportunities to connect with peers and those who can help you achieve your business goals. Check out our growing list of the events and receptions that BIO h
San Diego
14-15 June 2022
We are delighted to announce that this OCT UK is back in physical format on the 14-15 June. The 2022 program is currently under development and will be built through in-depth research with the local industry. Last year's event included talks from GSK
UK
London
15-18 August 2022
The Bioprocessing Summit 2022 For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocess R&D, scale-up, quality and analytics.
Boston
27-30 September 2022
THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS. Our scientific agenda features 7 conference tracks focused on improving efficiencies across all phases of biopharmac
04-05 October 2022
Professionally Curated Content …leading to meaningful discussions.
Netherlands
Amsterdam
12-13 October 2022
Arena International are delighted to announce Outsourcing in Clinical Trials New England will be returning to Boston on October 12th-13th 2022! For this years show we are thrilled to welcome Craig Lipset (Advisor and Founder, Clinical Innovation Part
01-03 November 2022
Leverage Partnerships and Collaborations to Achieve Greater Success for Your Facility & Portfolio of Biologics. Reduce Costs - Maintain Product Quality - Accelerate Speed to Market - Overcome Supply Chain Disruption. Learn from Today's Leading Cdmos
Germany
Frankfurt
05-08 December 2022
The European Cell and Gene Therapy Congress for ground-breaking manufacturing, commercialization and supply chain strategies. World renowned leaders share the latest analytical techniques & vector technologies to revolutionise your cell, gene & gene
27-02 March 2023
The BPI US West 2023 scientific agenda covers today's latest innovations across all phases of biopharmaceutical development and manufacturing. Your registration provides access to all 6 conference tracks and includes 12 months of on demand access to
05-08 June 2023
Join the Stand Up for Science movement at BIO 2023, happening from June 5-8. Let's celebrate and honor the invaluable contributions of biotech in driving innovation and uncovering truth for the betterment of society. This convention offers an excelle
14-14 August 2023
Identifying, acquiring and retaining the right talent is complicated, especially in today’s increasingly competitive and complex biopharma market. The exponential growth of the biopharmaceutical industry combined with the growing shortfall of experie
14-15 August 2023
Advances in host cell engineering, better expression of cell lines and optimization of cell culture processes, have greatly accelerated upstream processing in the last decade, resulting in today's antibody production yield of 10g/L or more. Meanwhile
Vaccines and mRNA-based vaccines have recently gained a lot of attention due to COVID-19. Cambridge Healthtech Institute’s 3rd Annual Vaccine Development and Manufacturing conference tackles the practical challenges facing the development, manufactur
Cambridge Healthtech Institute’s Gene Therapy CMC and Analytics conference uncovers the practical challenges facing the analysis, characterization, and quality of viral vector-based gene therapies for clinical and commercial supply, with dedicated se
The popular 11th Annual Rapid Methods to Assess Stability and Impurities in Biologics conference will bring together experts in formulation, analytical sciences, and process to discuss rapid and practical ways to accelerate prediction and screening f
Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the characterization, control, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representative
The biopharma industry is driven by the need to increase productivity, reduce cost, while maintaining product quality and consistency. Continuous biomanufacturing and process intensification are borne out of such need. CHI’s Intensified & Continuous
Characterizing and controlling process-related impurities, such as host cell proteins (HCPs), is a critical part of bioprocessing, with regulators now pressing companies for more data and questions emerging on the role of HCPs in emerging modalities.
14-17 August 2023
The Bioprocessing Summit 2023, now in its fifteenth year, stands as the premier global forum for industry leaders to converge and exchange groundbreaking advancements in bioprocess research and development, scale-up, quality, and analytics. This high
16-17 August 2023
The approval of COVID-19 vaccines was the breakthrough for mRNA-based technology, and it opened so many opportunities for mRNA-based vaccines and therapeutics. CHI’s 2nd Annual mRNA-Based Therapies conference will explore the technical challenges fac
Pharmaceutical companies today are increasingly harnessing the power of digitalization to drive scientific and operational excellence across the value chain, from R&D to manufacturing. Digitalization is a key enabler to smarter bioprocessing and to h
Industry analytical groups are facing increased pressure to deliver key studies faster than ever before – and at lower costs. Cambridge Healthtech Institute’s 10th Annual Accelerating Analytical Development conference offers a best practices forum in
Newer and more complex molecules coming down the pipeline are bringing a new set of challenges to the downstream process development team, leading to the search for innovative technologies to meet the demand for higher yield while maintaining product
The development of high-concentration protein formulations for traditional and novel biologic products can be challenging during manufacturing, storage, and delivery due to problems such as aggregation, precipitation, gelation, and high viscosity. Th
Cambridge Healthtech Institute’s Gene Therapy Manufacturing conference discusses the practical challenges facing the production, purification, and manufacturing of viral and non-vector-based gene therapies. Topics include: AAV and lentivirus upstream
CHI’s Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automat
21-22 August 2023
The 8th annual Liquid Biopsy for Disease Management: From Discovery to Clinical Use conference will review new liquid biopsies coming on the market that have increased sensitivity and are robust enough for clinical applications for measuring treatmen
Washington, DC
The point-of-care industry is poised for tremendous growth and is fueled by both the explosion of enabling technologies as well as the huge need for disruption in the medical sector as consumers demand flexibility and access to testing as well as fas
Development of companion diagnostics shows no signs of slowing down anytime soon. As the field continues to grow, it is critical that the surrounding landscape progresses with it. Partnerships between pharmaceutical and diagnostic companies can lead
22-23 August 2023
The increase in testing and demands of the COVID-19 pandemic has spurred tremendous innovation for infectious disease testing platforms that reduce time, cost, and offer greater access than ever before. At the 15th Annual Advanced Diagnostics for Inf
As diagnostics become increasingly complex, coverage and reimbursement come to the forefront of challenges that diagnostic companies face. Deep understanding of how policy is developed and implemented and how policy will change over time will provide
Current guidelines call for screening for only five types of cancer, and in each case for one type of cancer per screen. This means that there are no screening tests available for the majority of cancers, and far too often cancer is only detected onc
Within the last few years, we saw a seismic global shift in the acceptance and availability of point-of-care and home-based testing, bolstered by a heightened interest in and capability for decentralized processes. Healthcare systems and providers we
18-21 September 2023
Join us at the Cell & Gene Therapy Manufacturing & Commercialization US 2023, the premier event dedicated to revolutionizing the field of cell and gene therapy manufacturing, commercialization, and supply chain strategies. As the leading conference i
The Largest Bioprocessing Event is an annual conference held at the Boston Convention and Exhibition Center, focusing on accelerating the development and commercial success of promising biologics, cell therapies, and gene therapies. The event brings